Key Insights

Highlights

Success Rate

100% trial completion (above average)

Clinical Risk Assessment

Based on trial outcomes

Low Risk

Score: 15/100

Termination Rate

0.0%

0 terminated out of 9 trials

Success Rate

100.0%

+13.5% vs benchmark

Late-Stage Pipeline

22%

2 trials in Phase 3/4

Results Transparency

71%

5 of 7 completed with results

Key Signals

5 with results100% success

Data Visualizations

Phase Distribution

9Total
Not Applicable (5)
P 1 (2)
P 3 (2)

Trial Status

Completed7
Recruiting2

Trial Success Rate

100.0%

Benchmark: 86.5%

Based on 7 completed trials

Clinical Trials (9)

Research Network

Activity Timeline